Last update 04 Apr 2026

WO2025050066

Patent Mining

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms-
Target
TERT
Action
activators
Mechanism
TERT activators(Telomerase reverse transcriptase activators)
Therapeutic Areas
Immune System DiseasesNervous System DiseasesCardiovascular Diseases+ [6]
Active Indication
AtherosclerosisChronic Kidney DiseasesDiabetes Mellitus+ [5]
Inactive Indication-
Originator Organization
The Scripps Research InstituteThe Scripps Research InstituteThe Board of Regents of The University of Texas System
Active Organization
The Board of Regents of The University of Texas SystemThe Scripps Research InstituteThe Scripps Research Institute
Inactive Organization-
License Organization-
Drug Highest PhaseDiscovery
First Approval Date-
Regulation-

Related

100 Clinical Results associated with WO2025050066
Login to view more data
100 Translational Medicine associated with WO2025050066
Login to view more data
100 Patents (Medical) associated with WO2025050066
Login to view more data
100 Deals associated with WO2025050066
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
AtherosclerosisDiscovery-
The Scripps Research InstituteThe Scripps Research Institute
06 Mar 2025
AtherosclerosisDiscovery-
The Board of Regents of The University of Texas System
06 Mar 2025
Chronic Kidney DiseasesDiscovery-
The Board of Regents of The University of Texas System
06 Mar 2025
Chronic Kidney DiseasesDiscovery-
The Scripps Research InstituteThe Scripps Research Institute
06 Mar 2025
Diabetes MellitusDiscovery-
The Scripps Research InstituteThe Scripps Research Institute
06 Mar 2025
Diabetes MellitusDiscovery-
The Board of Regents of The University of Texas System
06 Mar 2025
Liver CirrhosisDiscovery-
The Scripps Research InstituteThe Scripps Research Institute
06 Mar 2025
Liver CirrhosisDiscovery-
The Board of Regents of The University of Texas System
06 Mar 2025
Nervous System DiseasesDiscovery-
The Scripps Research InstituteThe Scripps Research Institute
06 Mar 2025
Nervous System DiseasesDiscovery-
The Board of Regents of The University of Texas System
06 Mar 2025
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free